SLIT and NTRK-like protein 1 (SLITRK1)

SLIT and NTRK-like protein 1 (SLITRK1) is a transmembrane protein highly expressed in the human brain, predominantly at postsynaptic sites, and is part of the leucine-rich repeat protein family[1][3]. Structurally, SLITRK1 contains two extracellular leucine-rich repeat domains (LRR1 and LRR2) crucial for binding to presynaptic LAR family receptor protein tyrosine phosphatases (LAR-RPTPs), such as PTPRD and PTPRS, mediating synaptic adhesion and promoting excitatory synapse formation[1][2][3][4]. Overexpression stimulates postsynaptic differentiation, while inhibition specifically reduces excitatory synaptic development. SLITRK1 is cleaved by secretases, releasing extracellular and intracellular fragments, and its cytoplasmic domain can interact with proteins such as 14-3-3, dynamin1, and L1CAM, influencing neurite outgrowth, endocytosis, and neuronal signaling[5][6]. Mutations in the SLITRK1 gene have been associated with neuropsychiatric conditions, especially Tourette syndrome, obsessive-compulsive disorder, and schizophrenia, suggesting its critical roles in neuronal circuit formation and psychiatric disease susceptibility[3][4][6]. There are currently no direct drugs or biologics developed to target SLITRK1, but rare variants serve as potential biomarkers for patient selection or disease susceptibility. Safety considerations for targeting SLITRK1 involve the risk of disturbing normal brain development and synaptic homeostasis[4].

Other names

KIAA1910Leucine-rich repeat-containing protein 12LRRC12TTMUNQ233/PRO266slit and trk like gene 1SLIT and NTRK like family member 1

Not currently applicable as there are no drugs directly targeting this protein known at present[3][1]. Hypothetically, modulating SLITRK1 function could affect synaptogenesis and neuronal network formation via synaptic adhesion processes.